• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对新型冠状病毒肺炎(COVID-19)这一急性呼吸道传染病的医院饮食:一项临床试验的循证方案

Hospital diet for COVID-19, an acute respiratory infectious disease: An evidence-based Protocol of a Clinical Trial.

作者信息

Moslemifard Masoud, Gorji Narges, Ghadimi Reza, Kamalinejad Mohammad, Shirafkan Hoda, Mozaffarpur Seyyed Ali

机构信息

Department of Persian Medicine, School of Persian Medicine, Babol University of Medical Sciences, Babol, Iran.

Department of History of Medical Sciences, School of Persian Medicine, Babol University of Medical Sciences, Babol, Iran.

出版信息

Caspian J Intern Med. 2020 Fall;11(Suppl 1):466-478. doi: 10.22088/cjim.11.0.466.

DOI:10.22088/cjim.11.0.466
PMID:33425263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7780879/
Abstract

BACKGROUND

COVID-19 caused a global pandemic problem. No confident management is introduced for it yet. This study aimed to propose a dietary protocol for hospitalized patients with the diagnosis of acute respiratory infectious disease caused by COVID-19 based on Persian Medicine.

METHODS

This study was conducted in three phases. In the first phase, any diseases that could be matched with the clinical features of infection with COVID-19 were searched in selected PM references. In the second phase, medicinal herbs and foods that were available and could be used in the hospital diet were extracted and summarized. In the third phase, the new documentation of these pharmaceutical and food items was conducted.

RESULTS

The signs and symptoms of infectious respiratory disease caused by COVID-19 can be categorized in the field of Zato al-rieh that can mainly be matched with pneumonia. Based on the described criteria, some nutrients and medicinal materia medica have been introduced for acute respiratory infection including Cydonia oblonga, Honey, Citrus sinensis, Malus domestica, Citrus medica, Crocus sativus, Raisin, Rosa Damas Cena, D.Carota, Camellia Sinensis, Anethum graveolens dhi, Punica granatum, Petroselinum Crispum, Coriandrum sativum, Urtica dioica, Allium sativum, Sesamum indicum.

CONCLUSION

Most materia medica has documents in current articles including anti-cough suppressants, antiviral properties, anti-bacterial, anti-inflammatory, antioxidant, immunomodulatory etc. A protocol of hospital diet for patients with infectious respiratory syndrome caused by COVID-19 has been introduced in this manuscript.

摘要

背景

新型冠状病毒肺炎引发了全球大流行问题。目前尚未有可靠的治疗方法。本研究旨在基于波斯医学为确诊为新型冠状病毒肺炎所致急性呼吸道传染病的住院患者提出饮食方案。

方法

本研究分三个阶段进行。第一阶段,在选定的波斯医学参考文献中搜索任何可与新型冠状病毒肺炎感染临床特征相匹配的疾病。第二阶段,提取并总结医院饮食中可用的草药和食物。第三阶段,对这些药物和食物进行新的记录。

结果

新型冠状病毒肺炎所致传染性呼吸道疾病的体征和症状可归类于“Zato al-rieh”领域,主要可与肺炎相匹配。根据所述标准,已为急性呼吸道感染引入了一些营养物质和药材,包括榅桲、蜂蜜、甜橙、苹果、枸橼、藏红花、葡萄干、大马士革蔷薇、胡萝卜、茶、莳萝、石榴、欧芹、芫荽、荨麻、大蒜、芝麻。

结论

目前文章中大多数药材都有记载,包括止咳剂、抗病毒特性、抗菌、抗炎、抗氧化、免疫调节等。本手稿介绍了针对新型冠状病毒肺炎所致传染性呼吸综合征患者的医院饮食方案。

相似文献

1
Hospital diet for COVID-19, an acute respiratory infectious disease: An evidence-based Protocol of a Clinical Trial.针对新型冠状病毒肺炎(COVID-19)这一急性呼吸道传染病的医院饮食:一项临床试验的循证方案
Caspian J Intern Med. 2020 Fall;11(Suppl 1):466-478. doi: 10.22088/cjim.11.0.466.
2
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效:一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Herbal medicine use for the management of COVID-19: A review article.用于COVID-19管理的草药医学:一篇综述文章。
Metabol Open. 2021 Dec;12:100141. doi: 10.1016/j.metop.2021.100141. Epub 2021 Oct 16.
5
Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review.有前景的印度传统药用植物可用于治疗新型冠状病毒病:系统综述。
Phytother Res. 2021 Aug;35(8):4456-4484. doi: 10.1002/ptr.7150. Epub 2021 Jun 16.
6
Nine Steps to Discover New Medicines from Traditional Sources: The Example of Persian Medicine.从传统资源中发现新药的九个步骤:以波斯医学为例。
J Altern Complement Med. 2020 May;26(5):365-368. doi: 10.1089/acm.2019.0377. Epub 2020 Jan 10.
7
Laūq: A Sustained-Release Dosage Form for Respiratory Disorders in Traditional Persian Medicine.劳克:传统波斯医学中用于呼吸系统疾病的缓释剂型。
J Evid Based Complementary Altern Med. 2016 Jan;21(1):63-70. doi: 10.1177/2156587215587417. Epub 2015 May 24.
8
Efficacy of a Persian herbal medicine compound on coronavirus disease 2019 (COVID-19): A randomized clinical trial.一种波斯草药复方对2019冠状病毒病(COVID-19)的疗效:一项随机临床试验。
Integr Med Res. 2022 Sep;11(3):100869. doi: 10.1016/j.imr.2022.100869. Epub 2022 Jun 3.
9
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.沙利鲁单抗对比标准治疗用于住院 COVID-19 肺炎患者的早期治疗:SARTRE:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 16;21(1):794. doi: 10.1186/s13063-020-04633-3.
10
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.一项评估静脉注射瑞维鲁单抗对比 COVID-19 重症肺炎、急性肺损伤或急性呼吸窘迫综合征患者最佳支持治疗的疗效和安全性的 III 期开放性标签、随机对照研究:一项随机对照试验研究方案的结构性总结。
Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z.

引用本文的文献

1
Interferon Point Alteration in Hospitalized Patients with and Without COVID-19.新冠病毒感染与未感染住院患者的干扰素位点改变
Med Acupunct. 2024 Dec 17;36(6):343-349. doi: 10.1089/acu.2023.0095. eCollection 2024 Dec.
2
Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.影响 COVID-19 再入院和生存的合并症:联合脆弱模型的应用。
PLoS One. 2024 Apr 18;19(4):e0301209. doi: 10.1371/journal.pone.0301209. eCollection 2024.
3
Anticariogenic Activity of Black Tea: An In Vivo Study.红茶的防龋活性:一项体内研究。
Cureus. 2023 May 2;15(5):e38460. doi: 10.7759/cureus.38460. eCollection 2023 May.
4
An overview on role of nutrition on COVID-19 immunity: Accumulative review from available studies.营养对新冠病毒免疫力作用的概述:现有研究的累积综述
Clin Nutr Open Sci. 2023 Feb;47:6-43. doi: 10.1016/j.nutos.2022.11.001. Epub 2022 Nov 9.
5
Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspective.在 COVID-19 和类似呼吸道病毒疾病中的顺势疗法草药汤剂的治疗和姑息作用:植物化学和药理学观点。
J Ethnopharmacol. 2022 Oct 28;297:115526. doi: 10.1016/j.jep.2022.115526. Epub 2022 Jul 14.
6
Saffron for COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence.藏红花用于治疗与COVID-19相关的细胞因子风暴:炒作还是希望?对当前证据的简要综述
Metabol Open. 2021 Sep;11:100111. doi: 10.1016/j.metop.2021.100111. Epub 2021 Jul 21.

本文引用的文献

1
Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis.蜂蜜对上呼吸道感染症状缓解的疗效:系统评价和荟萃分析。
BMJ Evid Based Med. 2021 Apr;26(2):57-64. doi: 10.1136/bmjebm-2020-111336. Epub 2020 Aug 18.
2
Traditional Chinese medicine for COVID-19 treatment.用于治疗新冠肺炎的中药。
Pharmacol Res. 2020 May;155:104743. doi: 10.1016/j.phrs.2020.104743. Epub 2020 Mar 4.
3
Coronavirus Disease 2019 (COVID-19): A Perspective from China.2019 冠状病毒病(COVID-19):来自中国的视角。
Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21.
4
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病(COVID-19)?对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
5
Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China.中国 1 岁以下住院婴儿的新型冠状病毒感染。
JAMA. 2020 Apr 7;323(13):1313-1314. doi: 10.1001/jama.2020.2131.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).新型冠状病毒(2019-nCoV)感染的肺炎快速诊治指南(标准版)。
Mil Med Res. 2020 Feb 6;7(1):4. doi: 10.1186/s40779-020-0233-6.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Immunoregulatory and anti-inflammatory properties of (Saffron) and its main active constituents: A review.藏红花及其主要活性成分的免疫调节和抗炎特性:综述
Iran J Basic Med Sci. 2019 Apr;22(4):334-344. doi: 10.22038/ijbms.2019.34365.8158.
10
Effect of eryngo (Eryngium caucasicum Trautv) on primary dysmenorrhea: A randomized, double-blind, placebo-controlled study.刺芫荽(高加索刺芹)对原发性痛经的影响:一项随机、双盲、安慰剂对照研究。
Taiwan J Obstet Gynecol. 2019 Mar;58(2):227-233. doi: 10.1016/j.tjog.2019.01.011.